A systematic review of relapse rates in patients with relapsing multiple sclerosis during pregnancy and breastfeeding

被引：0
|
作者：
Sabido, M. [1 ]
Gillett, A. [1 ]
Marhardt, K. [1 ]
机构：
[1] Merck KGaA, Darmstadt, Germany
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO3194
引用
收藏
页码：856 / 856
页数：1
相关论文
共 50 条
  • [41] Estimation of sample size in randomized controlled trials in multiple sclerosis studying annualized relapse rates: A systematic review
    Poncet-Megemont, Louis
    Pereira, Bruno
    Rollot, Fabien
    Sormani, Maria Pia
    Clavelou, Pierre
    Moisset, Xavier
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (09) : 1457 - 1466
  • [42] Alemtuzumab: A Review of Its Use in Patients with Relapsing Multiple Sclerosis
    Garnock-Jones, Karly P.
    DRUGS, 2014, 74 (04) : 489 - 504
  • [43] Stress as a Risk Factor for Multiple Sclerosis Onset or Relapse: A Systematic Review
    Artemiadis, Artemios K.
    Anagnostouli, Maria C.
    Alexopoulos, Evangelos C.
    NEUROEPIDEMIOLOGY, 2011, 36 (02) : 109 - 120
  • [44] Trends in annualized relapse rates in relapsing-remitting multiple sclerosis and consequences for clinical trial design
    Nicholas, Richard
    Straube, Sebastian
    Schmidli, Heinz
    Schneider, Simon
    Friede, Tim
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (10) : 1211 - 1217
  • [45] Ocrelizumab reduces disability progression independent of relapse activity in patients with relapsing multiple sclerosis
    Kappos, L.
    Wolinsky, J. S.
    Giovannoni, G.
    Arnold, D. L.
    Lublin, F.
    Wang, Q.
    Model, F.
    Wei, W.
    Garren, H.
    Manfrini, M.
    Belachew, S.
    Hauser, S. L.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 309 - 310
  • [46] NATALIZUMAB REDUCES RELAPSE-ASSOCIATED COSTS OF HOSPITALIZATIONS IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS
    O'Day, K.
    Meyer, K.
    Rajagopalan, K.
    VALUE IN HEALTH, 2008, 11 (06) : A605 - A605
  • [47] Ofatumumab Reduces Disability Progression Independent of Relapse Activity in Patients with Relapsing Multiple Sclerosis
    Montalban, Xavier
    Cohen, Jeffrey A.
    Comi, Giancarlo
    Coyle, Patricia K.
    Kappos, Ludwig
    Li, Bingbing
    Sfikas, Nikolaos
    Willi, Roman
    Haring, Dieter A.
    Merschhemke, Martin
    Hauser, Stephen L.
    NEUROLOGY, 2020, 94 (15)
  • [48] Ofatumumab Reduces Disability Progression Independent of Relapse Activity in Patients with Relapsing Multiple Sclerosis
    Kappos, Ludwig
    Montalban, Xavier
    Coyle, Patricia
    Nicholas, Jacqueline
    Meuth, Sven
    Li, Bingbing
    Ramanathan, Krishnan
    Su, Wendy
    Willi, Roman
    Haering, Dieter A.
    Hauser, Stephen
    NEUROLOGY, 2021, 96 (15)
  • [49] Daclizumab: A Review in Relapsing Multiple Sclerosis
    Matt Shirley
    Drugs, 2017, 77 : 447 - 458
  • [50] Daclizumab: A Review in Relapsing Multiple Sclerosis
    Shirley, Matt
    DRUGS, 2017, 77 (04) : 447 - 458
12345